Rheumatology & Immunology
The Division of Rheumatology & Immunology has a long tradition of providing outstanding care to patients of all ages who suffer from rheumatic diseases. Our commitment to patient care extends to active engagement in research designed to understand the pathogenesis of connective tissue diseases and to improve outcomes for patients with rheumatic diseases.
The Division has earned an international reputation for its care and research relating to two autoimmune connective tissue diseases - Scleroderma and Lupus. The Division was recently approved for the creation of the MUSC Inflammation and Fibrosis Research Center of Economic Excellence through the South Carolina Centers of Economic Excellence Program which focuses on clinical and translational research related to both scleroderma and lupus.
A wide range of services is provided, including comprehensive consultative care, infusion therapies, bone density assessments and musculoskeletal ultrasound.
We work closely with the team at the MUSC Children’s Hospital Pediatric Rheumatology program to provide outstanding care to children with f autoimmune diseases, musculoskeletal pain syndromes, periodic and prolonged fever conditions, multisystem inflammatory conditions, and connective tissue diseases.
MUSC Health is proud to have earned U.S. News & World Report 2018 – 2019 high-performing hospital designation in Rheumatology.
Health Focus Podcasts
Bobbi Connor of South Carolina Public Radio interviews Dr. Jim Oates, Associate Director of the Division of Rheumatology at MUSC Health, about the following topics: